Humam Kadara

10.4k citations

95 papers · 3.2k indexed · h-index 34

Cancer Research top 2%
- Cancer Genomics and Diagnostics 24
Oncology top 2%
- Cancer Immunotherapy and Biomarkers 10
- Cytokine Signaling Pathways and Interactions 9
- Cancer Cells and Metastasis 7
Pulmonary and Respiratory Medicine top 2%
- Lung Cancer Treatments and Mutations 31
- Lung Cancer Diagnosis and Treatment 8
Molecular Biology top 5%
- RNA modifications and cancer 19
Immunology top 5%
- Immune cells in cancer 8

Co-authors: Ignacio I. Wistuba Carmen Behrens Reuben Lotan J. Jack Lee Dafna Lotan Junya Fujimoto Luisa M. Solis Zahraa Rahal
Cited by: Cancer Research Oncology Pulmonary and Respiratory Medicine
Journals: Journal of Clinical Investigation (1 paper)Nature Communications (1 paper)Journal of Clinical Oncology (2 papers)
Partner nations: United States Lebanon Japan

In The Last Decade

Humam Kadara

91 papers receiving 3.2k citations

Peers

Countries citing papers authored by Humam Kadara

Since Specialization

Citations

This map shows the geographic impact of Humam Kadara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Humam Kadara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Humam Kadara more than expected).

Fields of papers citing papers by Humam Kadara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Humam Kadara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Humam Kadara. The network helps show where Humam Kadara may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Humam Kadara, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Humam Kadara Line = papers co-authored together Humam Kadara links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Tumour and microenvironment crosstalk in NSCLC progression and response to therapy Nature Reviews Clinical Oncology ·Zahraa Rahal,Roy El Darzi,Seyed Javad Moghaddam,Tina Cascone,Humam Kadara	2025	7
2	Targeting IL-1β as an immunopreventive and therapeutic modality for K-ras–mutant lung cancer JCI Insight ·Bo Yuan,Michael J. Clowers,Walter V. Velasco,Stephen Peng,Qian Peng,Yewen Shi,Marco Ramos-Castañeda,Melody Zarghooni,Shuanying Yang,Rachel L. Babcock,Seon Hee Chang,John V. Heymach,Jianjun Zhang,Edwin J. Ostrin,Stephanie S. Watowich,Humam Kadara,Seyed Javad Moghaddam	2022	43
3	Anti-Tumor Effects of Biomimetic Sulfated Glycosaminoglycans on Lung Adenocarcinoma Cells in 2D and 3D In Vitro Models Molecules ·Nada Al Matari,George Deeb,Hiba Mshiek,Ansam Sinjab,Humam Kadara,Wassim Abou‐Kheir,Rami Mhanna	2020	11
4	Field Carcinogenesis in Cancer Evolution: What the Cell Is Going On? Cancer Research ·Ansam Sinjab,Guangchun Han,Linghua Wang,Humam Kadara	2020	15
5	IL22 Promotes Kras -Mutant Lung Cancer by Induction of a Protumor Immune Response and Protection of Stemness Properties Cancer Immunology Research ·Nasim Khosravi,Mauricio S. Caetano,Amber M. Cumpian,Neşe Ünver,Cynthia De la Garza‐Ramos,Oscar Noble,Soudabeh Daliri,Belinda Hernández,Berenice A. Gutierrez,Scott E. Evans,Samir Hanash,Andrei M. Alekseev,Yi Yang,Seon Hee Chang,Roza Nurieva,Humam Kadara,Jichao Chen,Edwin J. Ostrin,Seyed Javad Moghaddam	2018	49
6	Genome-Wide Gene Expression Changes in the Normal-Appearing Airway during the Evolution of Smoking-Associated Lung Adenocarcinoma Cancer Prevention Research ·Jacob Kantrowitz,Ansam Sinjab,Xu Li,Tina L. McDowell,Smruthy Sivakumar,Wenhua Lang,Sayuri Nunomura‐Nakamura,Junya Fukuoka,Georges Nemer,Nadine Darwiche,Hassan Chami,Arafat Tfayli,Ignacio I. Wistuba,Paul Scheet,Junya Fujimoto,Avrum Spira,Humam Kadara	2018	15
7	Genomics of adult and pediatric solid tumors. Europe PMC (PubMed Central) ·Zahraa Rahal,Farah Abdulhai,Humam Kadara,Raya Saab	2018	33
8	Distinct pattern of TP53 mutations in human immunodeficiency virus–related head and neck squamous cell carcinoma Cancer ·Frederico O. Gleber‐Netto,Mei Zhao,Sanchit Trivedi,Jiping Wang,Samar A. Jasser,Christina McDowell,Humam Kadara,Jiexin Zhang,Jing Wang,William N. William,J. Jack Lee,Minh Ly Nguyen,Sara I. Pai,Heather M. Walline,Dong M. Shin,Robert L. Ferris,Thomas E. Carey,Jeffrey N. Myers,Curtis R. Pickering	2017	18
9	Image Analysis–based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non–small Cell Lung Carcinoma Patients Clinical Cancer Research ·Edwin R. Parra,Carmen Behrens,Jaime Rodriguez‐Canales,Heather Lin,Barbara Mino,Jorge Blando,Jianjun Zhang,Don L. Gibbons,John V. Heymach,Boris Sepesi,Stephen G. Swisher,Annikka Weissferdt,Neda Kalhor,Julie Izzo,Humam Kadara,César A. Moran,J. Jack Lee,Ignacio I. Wistuba	2016	103
10	IL6 Blockade Reprograms the Lung Tumor Microenvironment to Limit the Development and Progression of K-ras–Mutant Lung Cancer Cancer Research ·Mauricio S. Caetano,Huiyuan Zhang,Amber M. Cumpian,Lei Gong,Neşe Ünver,Edwin J. Ostrin,Soudabeh Daliri,Seon Hee Chang,Cesar E. Ochoa,Samir Hanash,Carmen Behrens,Ignacio I. Wistuba,Cinthya Sternberg,Humam Kadara,Carlos Gil Ferreira,Stephanie S. Watowich,Seyed Javad Moghaddam	2016	169
11	ETS2 Mediated Tumor Suppressive Function and MET Oncogene Inhibition in Human Non–Small Cell Lung Cancer Clinical Cancer Research ·Mohamed Kabbout,Melinda Garcia,Junya Fujimoto,Diane D. Liu,Denise M. Woods,Chi‐Wan Chow,Gabriela Mendoza,Amin A. Momin,Brian P. James,Luisa M. Solis,Carmen Behrens,J. Jack Lee,Ignacio I. Wistuba,Humam Kadara	2013	116
12	Prediction of Survival in Resected Non–Small Cell Lung Cancer Using a Protein Expression–Based Risk Model: Implications for Personalized Chemoprevention and Therapy Clinical Cancer Research ·Kathryn A. Gold,Edward S. Kim,Diane D. Liu,Ping Yuan,Carmen Behrens,Luisa M. Solis,Humam Kadara,David C. Rice,Ignacio I. Wistuba,Stephen G. Swisher,Wayne L. Hofstetter,J. Jack Lee,Waun Ki Hong	2013	27
13	EZH2 Protein Expression Associates with the Early Pathogenesis, Tumor Progression, and Prognosis of Non–Small Cell Lung Carcinoma Clinical Cancer Research ·Carmen Behrens,Luisa M. Solis,Heather Lin,Ping Yuan,Ximing Tang,Humam Kadara,Erick Riquelme,Héctor Galindo,César A. Moran,Neda Kalhor,Stephen G. Swisher,George R. Simon,David J. Stewart,J. Jack Lee,Ignacio I. Wistuba	2013	123
14	Characterizing the Molecular Spatial and Temporal Field of Injury in Early-Stage Smoker Non–Small Cell Lung Cancer Patients after Definitive Surgery by Expression Profiling Cancer Prevention Research ·Humam Kadara,Li Shen,Junya Fujimoto,Pierre Saintigny,Chi‐Wan Chow,Wenhua Lang,Zuoming Chu,Melinda Garcia,Mohamed Kabbout,You-Hong Fan,Carmen Behrens,Diane A. Liu,Li Mao,J. Jack Lee,Kathryn A. Gold,Jing Wang,Kevin R. Coombes,Edward S. Kim,Waun Ki Hong,Ignacio I. Wistuba	2012	26
15	Abnormalities of the TITF-1 Lineage-Specific Oncogene in NSCLC: Implications in Lung Cancer Pathogenesis and Prognosis Clinical Cancer Research ·Ximing Tang,Humam Kadara,Carmen Behrens,Diane D. Liu,Yun Xiao,David C. Rice,Adi F. Gazdar,Junya Fujimoto,César A. Moran,Marileila Varella‐Garcia,J. Jack Lee,Waun Ki Hong,Ignacio I. Wistuba	2011	59
16	A Five-Gene and Corresponding Protein Signature for Stage-I Lung Adenocarcinoma Prognosis Clinical Cancer Research ·Humam Kadara,Carmen Behrens,Ping Yuan,Luisa M. Solis,Diane Liu,Xuemin Gu,John D. Minna,J. Jack Lee,Edward Kim,Waun-Ki Hong,Ignacio I. Wistuba,Reuben Lotan	2010	68
17	Gprc5a Deletion Enhances the Transformed Phenotype in Normal and Malignant Lung Epithelial Cells by Eliciting Persistent Stat3 Signaling Induced by Autocrine Leukemia Inhibitory Factor Cancer Research ·Yulong Chen,Jiong Deng,Junya Fujimoto,Humam Kadara,Taoyan Men,Dafna Lotan,Reuben Lotan	2010	44
18	Knockout of the Tumor Suppressor Gene Gprc5a in Mice Leads to NF-κB Activation in Airway Epithelium and Promotes Lung Inflammation and Tumorigenesis Cancer Prevention Research ·Jiong Deng,Junya Fujimoto,Xiao-Feng Ye,T. Men,Carolyn S. Van Pelt,Yu-Long Chen,Xiao-Feng Lin,Humam Kadara,Qingguo Tao,Dafna Lotan,Reuben Lotan	2010	65
19	Identification of Gene Signatures and Molecular Markers for Human Lung Cancer Prognosis using an In vitro Lung Carcinogenesis System Cancer Prevention Research ·Humam Kadara,Ludovic Lacroix,Carmen Behrens,Luisa M. Solis,Xuemin Gu,J. Jack Lee,E Tahara,Dafna Lotan,Waun Ki Hong,Ignacio I. Wistuba,Reuben Lotan	2009	49
20	Expression of Interleukin-1 Receptor–Associated Kinase-1 in Non–Small Cell Lung Carcinoma and Preneoplastic Lesions Clinical Cancer Research ·Carmen Behrens,Lei Feng,Humam Kadara,Hyun Jung Kim,J. Jack Lee,Reza J. Mehran,Waun Ki Hong,Reuben Lotan,Ignacio I. Wistuba	2009	33

About Humam Kadara

Humam Kadara is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 95 papers that have together received 3.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (31 papers), Cancer Genomics and Diagnostics (24 papers), RNA modifications and cancer (19 papers), Cancer Immunotherapy and Biomarkers (10 papers), Cytokine Signaling Pathways and Interactions (9 papers), Lung Cancer Diagnosis and Treatment (8 papers), Immune cells in cancer (8 papers) and Cancer Cells and Metastasis (7 papers). The work is most often cited by research in Cancer Research (900 citations), Oncology (1.1k citations) and Pulmonary and Respiratory Medicine (914 citations). Humam Kadara has collaborated with scholars based in United States, Lebanon and Japan. Frequent co-authors include Ignacio I. Wistuba, Carmen Behrens, Reuben Lotan, J. Jack Lee, Dafna Lotan, Junya Fujimoto, Luisa M. Solis, Zahraa Rahal, Ansam Sinjab and Raya Saab. Their work appears in journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact